- Home
- CRIS
CRIS
Curis Inc.
as 07-26-2024 4:00pm EST
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Upcoming Earnings Alert:
Get ready for potential market movements as Curis Inc. CRIS prepares to release earnings report on 01 Aug 2024.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | 46.9M | IPO Year: | 2000 |
| Target Price: | $37.33 | AVG Volume (30 days): | 30.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.38 - $17.49 | Next Earning Date: | 08-01-2024 |
| Revenue: | $9,812,000 | Revenue Growth: | -5.67% |
| Revenue Growth (this year): | -10.93% | Revenue Growth (next year): | 0.49% |
Latest Curis Inc. News
CRIS Breaking Stock News: Dive into CRIS Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
PR Newswire
17 days ago
Curis to Present at Upcoming Healthcare Conference in July
Zacks
17 days ago
What Makes Curis (CRIS) a New Buy Stock
PR Newswire
19 days ago
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
2 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Compare CRIS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRIS Curis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.